MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
14.98
+0.18
+1.22%
Opening 10:39 03/14 EDT
OPEN
15.00
PREV CLOSE
14.80
HIGH
15.29
LOW
14.89
VOLUME
30.70K
TURNOVER
--
52 WEEK HIGH
15.29
52 WEEK LOW
4.750
MARKET CAP
351.30M
P/E (TTM)
-4.9203
1D
5D
1M
3M
1Y
5Y
1D
Benitec - Another Biopharma Rocket
Barchart · 1d ago
Weekly Report: what happened at BNTC last week (0303-0307)?
Weekly Report · 4d ago
Weekly Report: what happened at BNTC last week (0224-0228)?
Weekly Report · 03/03 12:06
Piper Sandler Sticks to Their Buy Rating for Benitec Biopharma (BNTC)
TipRanks · 02/26 12:09
Weekly Report: what happened at BNTC last week (0217-0221)?
Weekly Report · 02/24 12:05
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Benitec Biopharma (BNTC) and Ardelyx (ARDX)
TipRanks · 02/21 11:40
Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
NASDAQ · 02/20 14:55
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable
NASDAQ · 02/20 13:50
More
About BNTC
More
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.
Recently
Symbol
Price
%Change

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.